OnCore Login

Return to Trial Database

HCRN-GI17-319

A single arm, multi-center Phase 2 trial of mFOLFOX6 + trastuzumab + avelumab in first-line, metastatic, HER2-amplified gastric and esophageal adenocarcinoma

 

Status

Study Completed

Cancer Type(s)

Gastric

Study Contact

Publications

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma
  • MS Lee, J Chao, MF Mulcahy, PM Kasi, AT Alistar, S Mukherjee, M Akce, DT Moore, CA Carlson, AJ McRee

Trial Locations

All sites in which the trial HCRN-GI17-319 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278